Global Neurodegenerative Disease Treatment Market to Reach US$ 114.6 Billion by 2032, Accelerated by Growing Prevalence of Tumors and Stroke

March 30, 2023 | Healthcare

As per the latest report by IMARC Group, titled "Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-methyl-D-aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032," the global neurodegenerative disease treatment market size reached US$ 74.7 Billion in 2023. Neurodegenerative diseases characterized are by the progressive degeneration of nerve cells, leading to cognitive and motor function loss. These conditions often result in significant physical and emotional distress for the patient and can have a devastating impact on their quality of life. Some of the early symptoms of the disease include memory loss, difficulty in thinking and problem-solving, mood swings, tremors, and difficulty in movement. Neurodegenerative disease treatments focus on slowing or halting the progression of the disease and involve medications, physical therapy, or surgical interventions. The growing cases of neurodegenerative diseases have compelled researchers to develop new and effective methods of diagnosing and treating these conditions. Among these, molecular diagnostics, such as biomarkers and imaging spectroscopy, are witnessing significant popularity.

Global Neurodegenerative Disease Treatment Market Trends: 

The surging alcohol consumption has considerably increased the incidence of tumors and stroke, which represents one of the primary factors boosting the market growth. This is further bolstered by the burgeoning geriatric population and the growing prevalence of neurodegenerative diseases. Besides this, the increasing demand for molecular diagnostic treatments for the early detection of neurodegenerative disorders and rising healthcare expenditure are providing an impetus to the market growth. In line with this, researchers are utilizing neuropathological and molecular biology techniques to better understand the classification of these diseases and develop minimally invasive (MI) screening tests, which, in turn, is boosting the market growth. Additionally, governments of several countries are organizing health education campaigns to raise awareness about the risk factors of neurodegenerative diseases, which is fueling the market growth. Apart from this, the rapidly expanding healthcare infrastructure and increasing disposable income are creating a positive outlook for the market. Looking forward, the market value is projected to reach US$ 114.6 Billion by 2032, expanding at a CAGR of 4.7% during 2024-2032. 

Market Summary: 

  • Based on the indication, the market has been segregated into multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, spinal muscular atrophy (SMA), Huntington’s disease, and others. 
  • On the basis of drug type, the market has been divided into N-methyl-D-aspartate receptor antagonists, selective serotonin reuptake inhibitors, dopamine inhibitors, and others.
  • By the route of administration, the market is categorized into oral, injectable, and others.
  • Based on the distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and others.
  • Regionally, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. 
  • The competitive landscape of the market has also been examined, with some of the key players being Biogen, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd. and UCB S.A.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Indication, Drug Type, Route of Administration, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Biogen, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd. and UCB S.A
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Neurodegenerative Disease Treatment Market to Reach US$ 114.6 Billion by 2032, Accelerated by Growing Prevalence of Tumors and Stroke
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More